Market Moving Insight and Analysis. Join Jim Kramer, David Faber, and me, Carl Kintania, on the opening bell hour of CNBC Squawk on the Street. Good Monday morning. Welcome to Squawk on the street. I'm Carl Kintania with Jim Kramer and David Faber at Post 9 of the New York Stock Exchange. Coming off the worst week since April, stock's trying to find some heart. And last night, Senate vote that might carve a path to the end of the longest government

shutdown in history.

Ten year 411, VIX is still holding 18.

Our roadmap begins with that shutdown, the longest, as we said, might be nearing an end as

the Senate passes the first stage of this deal.

Plus a big reality check for the AI trade, of course, tech stocks coming off.

One of the worst weeks they've seen in about seven months.

And Pfizer's the winner.

Yep, that bidding war for Metzara could be a deal worth as much as $10 billion.

We all have him.

He'll be joining us right here post nine very shortly.

Albert Borla, the CEO of the company. Let's begin with this tentative deal aimed at ending the shutdown. The Senate

clearing this procedural hurdle with a 60-40 vote passed with eight Democrats joining all Republicans

except for one deal funds the government through Jan 30. Would fully fund snap and reverse some of those attempted layoffs of federal workers.

Does not guarantee the health care subsidies the Democrats have been pushing for,

but there is the promise of a vote.

We're watching Rand Paul, whether he might slow walk this.

And, of course, the House, Jim, is important, too.

Well, we said last year that the end

two years ago the shutdown ended because of flying and not enough air traffic controllers well

having been caught in the chaos where you're supposed to leave at the airport at nine and it turns

it turns out to be a m and you're on a red eye. This is not

...